91.5FM
91.5HD2
8.85 c91.5 FM
91.5 HD2
Feds recover $40M from defunct Quebec vaccine developer Medicago
BY The Canadian Press, Dec 8, 2023 8:13 PM - REPORT AN ERRORThe federal government says it has recovered $40 million from the now-defunct Quebec-based vaccine developer Medicago, and the intellectual property will remain in Canada under a new firm.
The government provided Medicago a $173-million advance in the early days of the COVID-19 pandemic to develop and produce a plant-based vaccine in Quebec City. The company's Japanese parent company, Mitsubishi Chemical Group, shut down Medicago's operations in February as global demand for vaccinations plummeted.
Though Medicago's vaccine was approved for use in Canada, it was not approved by the World Health Organization due to the company's ties with tobacco giant Philip Morris. Aramis Biotechnologies is also based in Quebec City and is led by former Medicago employees.
Share on
Related News
Sign up for the newsletter
We'll deliver best of entertainment right into your inboxWe love to hear from our listeners, so feel free to send us message
Message us on whatsapp
